Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.
Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood. 2000 Jan 15; 95(2):619-26.
View in:
PubMed
subject areas
B-Lymphocytes
Carrier Proteins
Cell Cycle Proteins
Cyclin-Dependent Kinase Inhibitor p21
Cyclin-Dependent Kinase Inhibitor p27
Cyclin-Dependent Kinases
Cyclins
Cysteine Endopeptidases
DNA-Binding Proteins
E2F Transcription Factors
E2F1 Transcription Factor
Humans
Ki-67 Antigen
Lymphoid Tissue
Lymphoma
Lymphoma, B-Cell, Marginal Zone
Lymphoma, Mantle-Cell
Microtubule-Associated Proteins
Multienzyme Complexes
Proteasome Endopeptidase Complex
Retinoblastoma-Binding Protein 1
Survival Rate
Transcription Factor DP1
Transcription Factors
Tumor Suppressor Protein p53
Tumor Suppressor Proteins
authors with profiles
Roberto Chiarle, M.D.